Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - A possible mechanism

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1385-1393

  Budziszewska, Bogusława ^a   Jaworska Feil, Lucylla ^a   Kajta, Małgorzata ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressant drugs; Fibroblast cells; GR mediated gene transcription; Kinase activators; Kinase inhibitors

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; CORTICOSTEROID; CYCLIC GMP DEPENDENT PROTEIN KINASE; DESIPRAMINE; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; MIANSERIN; MIFEPRISTONE; MOCLOBEMIDE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DNA BINDING; DRUG MECHANISM; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033913717     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703445     Document Type: Article

References (43)

1. ADCOCK, I.M., NASUHARA, Y., STEVENS, D.A. & BARNES, P.J. (1999). Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-κB and lack of I-κB involvement. Br. J. Pharmacol., 127, 1003-1011.
2. BOURON, A. & CHATTON, J.Y. (1999). Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus. Neuroscience, 90, 729-736.
3. BRADY, L.S., WHITFIELD, H.J., FOX, R.J., GOLD, P.W. & HERKENHAM, M. (1991). Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J. Clin. Invest., 87, 831-837.
4. BUDZISZEWSKA, B., SIWANOWICZ, J. & PRZEGALIŃSKI, E. (1994). The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus. Pol. J. Pharmacol., 46, 147-152.
5. 2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase. Endocrinology, 140, 1639-1648.
6. CHEN, C.C., WANG, J.K. & CHEN, W.C. (1997). TPA induces translocation but not down-regulation of new PKC isoform η in macrophages, MDCK cells and astrocytes. FEBS Lett., 412, 30-34.
7. CZYRAK, A., MOGILNICKA, E., SIWANOWICZ, J. & MAJ, J. (1990). Some behavioural effects of repeated administration of calcium channel antagonists. Pharmacol. Biochem Behav., 35, 557-560.
8. FOWLER, C.J. & BRÄNNSTRÖM, G. (1990). Reduction in β-adrenoceptor density in cultured rat glioma C6 cells after incubation with antidepressants is dependent upon the culturing conditions used. J. Neurochem., 55, 245-250.
9. FRECHILLA, D., OTANO, A. & DEL RIO, J. (1998). Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex. Prog. Neuro-Psychopharmacol. Biol. Psychiat., 22, 787-802.
10. GLOTZBACH, R.K. & PRESKORN, S.H. (1982). Brain concentration of tricyclic antidepressants: single-dose kinetics and relationship to plasma concentrations in chronically doses rats. Psychopharmacology, 78, 25-27.
11. GUARDIOLA-DIAZ, H.M., KOLINSKE, J.S., GATES, L.H. & SEA-SHOLTZ, A.F. (1996). Negative glucocorticoid regulation of cyclic adenosinc 3′,5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells. Mol. Endocrinol., 10, 317-329.
12. HORGAN, K., COOKE, E., HALLETT, M.B. & MANSEL, R.E. (1986). Inhibition of protein kinase C mediated signal transduction by tamoxifen. Bioch. Pharmacol., 35, 4463-4465.
13. HRDINA, P.D. & DUBAS, T.C. (1981). Brain distribution and kinetics of desipramine in the rat. Can. J. Physiol. Pharmacol., 59, 163-167.
14. JACKSON, I.M. & LUO, L.G. (1998). Antidepressants inhibit the glucocorticoid stimulation of thyrotropin releasing hormone expression in cultured hypothalamic neurons. J. Investig. Med., 46, 470-474.
15. LAAKMANN, G. (1983). Antidepressants. In Clinical Psychopharmacology, ed. Hippius, H. & Winokur, G. pp. 86-96. Amsterdam, Oxford, Princeton: Excerpta Medica.
16. LOWRY, O.H., ROSENBROUGH, N.J., FARR, A.L. & RANDALL, R.J. (1951). Protein measurement with the Polin phenol reagent. J. Biol. Chem., 193, 265-275.
17. MACIEJEWSKI, D., CROWE, P.D., DE SOUZA, E.B. & BEHAN, D.P. (1996). Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes. J. Pharmacol. Exp. Ther., 278, 455-461.
18. 2+ channel blockade changes the behavioral and biochemical effects of immobilization stress. Neuropsychopharmacology, 20, 248-254.
19. MANN, C.D., VU, T.B. & HRDINA, P.D. (1995). Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. Br. J. Pharmacol., 115, 595-600.
20. MARODER, M., FARINA, A.R., VACCA, A., PIA FELLI, M., MECO, D., SCREPANTl, I., FRATI, L. & GULINO, A. (1993). Cell-specific bifunctional role of jun oncogene family members on glucocorticoid receptor-dependent transcription. Mol. Endocrinol., 7, 570-584.
21. MIGLIACCIO, A., ROTONDI, A. & AURICCHIO, F. (1984). Calmodulin-stimulated phosphorylation of 17 β-estradiol receptor on tyrosine. Proc. Natl. Acad. Sci. USA, 81, 5921-5925.
22. MIYAKE, K., FUKUCHI, H., KITAURA, T., KIMURA, M., SARAI, K. & NAKAHARA, T. (1990). Pharmacokinetics of amitriptyline and its demetylated metabolite in serum and specific brain regions of rats after acute and chronic administration of amitriptyline. J. Pharmaceut. Sci., 79, 288-291.
23. MOYER, M.L., BORROR, K.C., BONA, B.J., DEFRANCO, D.B. & NORDEEN, S.K. (1993). Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J. Biol. Chem., 268, 22933-22940.
24. NALEPA, I. & VETULANI, J. (1991). Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat. Neuroscience, 44, 585-590.
25. NIBUYA, M., MORINOBU, S. & DUMAN, R.S. (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neuroscience, 15, 7539-7547.
26. NIBUYA, M., NESTLER, E.J. & DUMAN, R.S. (1996). Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neuroscience, 16, 2365-2372.
27. NING, Y.-M. & SANCHEZ, E.R. (1995). Evidence for a functional interaction between calmodulin and the glucocorticoid receptor. Bioche. Biophys. Res. Commun., 208, 48-54.
28. NORDEEN, S.K., BONA, B.J. & MOYER, M.L. (1993). Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol. Endocrinol., 7, 731-742.
29. NORDEEN, S.K., MOYER, M.L. & BONA, B.J. (1994). The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology, 134, 1723-1732.
30. OKUGAWA, G., OMORI, K., SUZUKAWA, J., FUJISEKI, Y., KINOSHITA, T. & INAGAKI, C. (1999). Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones. J. Neuroendocrinol., 11, 887-895.
31. PARIANTE, C.M., PEARCE, B.D., PISELL, T.L., OWENS, M.J. & MILLER, A.H. (1997). Steroid independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol., 51, 571-581.
32. PEIFFER, A., VEILLEUX, S. & BARDEN, N. (1991). Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology, 16, 505-515.
33. PFEFFER, L.M., EISENKRAFT, B.L., REICH, N.C., IMPROTA, T., BAXTER, G., DANIEL-ISSAKANI, S. & STRULOVICI, B. (1991). Transmembrane signaling by interferon α involves diacylglycerol production and activation of the ε isoform of protein kinase C in Daudi cells. Proc. Natl. Acad. Sci. U.S.A., 88, 7988-7992.
34. PEPIN, M.-C., GOVINDAN, M.V. & BARDEN, N. (1992). Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol., 41, 1016-1022.
35. PRZEGALIŃSKI, E. & BUDZISZEWSKA, B. (1993). The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett., 161, 215-218.
36. SCHAAF, M.J.M., DE JONG, J., DE KLOET, E.R. & VREUGDENHIL, E. (1998). Downregulalion of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res., 813, 112-120.
37. SCHWANINGER, M., SCHOFL, C., BLUME, R., ROSSIG, L. & KNEPEL, W. (1995). Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol. Pharmacol., 47, 1112-1118.
38. SECKL, J.R. & FINK, G. (1992). Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology, 55, 621-626.
39. 2+ regulated myosin phosphorylation by fluoxetine and iprindole. Eur. J. Pharmacol., 121, 65-71.
40. 3 rat pituitary cells. Endocrinology, 131, 1883-1888.
41. WATANABE, Y., GOULD, E., DANIELS, D.C., CAMERON, H. & MCEWEN, B.S. (1992). Tianeptine attenuates stress-induced morphological changes in the hippocampus. J. Pharmacol., 222, 157-162.
42. WEBB, M.L., FLYNN, J.J., SCHMIDT, T.J., MARGULES, D.L. & LITWACK, G. (1986). Decreased glucocorticoid binding and receptor activation in brain of genetically diabetic (MDB/MDB) mice. J. Steroid Biochem., 25, 649-657.
43. WONG, K.L., CHUANG, T.Y., BRUCH, R.C. & FARBMAN, A.I. (1993). Amitriptyline inhibits neurite outgrowth in chick cerebral neurons: a possible mechanism. J. Neurobiol., 24, 474-487.